Intraarterial chemotherapy for brain tumors by using a spatial dose fractionation algorithm and pulsatile delivery

被引:52
作者
Gobin, YP [1 ]
Cloughesy, TF [1 ]
Chow, KL [1 ]
Duckwiler, GR [1 ]
Sayre, JW [1 ]
Milanese, K [1 ]
Viñuela, F [1 ]
机构
[1] Univ Calif Los Angeles, Med Ctr, Dept Radiol, Los Angeles, CA 90095 USA
关键词
brain neoplasms; MR; therapeutic radiology; chemotherapy; complications; regional;
D O I
10.1148/radiology.218.3.r01mr41724
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
PURPOSE: To evaluate the cause of complications in intraarterial chemotherapy for brain tumors and validate a dosage algorithm based on arterial territory. MATERIALS AND METHODS: Four hundred sixty-two procedures were performed in 113 patients. Technique included pulsatile infusion of a chemotherapeutic agent. Dosage was calculated per hemisphere and divided per arterial territory according to a spatial dose fractionation algorithm based on the vascular territories of major cerebral arteries: middle cerebral artery, 60%; anterior cerebral artery, 20%; posterior cerebral artery, 15%; and perforator arteries, 5%. Hospital charts of all patients were retrospectively reviewed for complications, with specific attention given to the angiograms to determine a cause. Then, subgroup analysis of the chemotherapy protocol with the largest patient population was performed to evaluate predictors of complications. RESULTS: Six (1.3%) complications were asymptomatic; 12 (2.6%), transient neurologic; three (0.6%), permanent minor neurologic; three (0.6%), permanent major neurologic; and 32 (7.0%), seizures. In the subgroup analysis, the hemispheric dose administered according to the algorithm was strongly predictive of seizure and neurologic deficit. CONCLUSION: Neurotoxicity of intraarterial cerebral chemotherapy can be minimized by using pulsatile injection and the described spatial dose fractionation algorithm.
引用
收藏
页码:724 / 732
页数:9
相关论文
共 37 条
[1]
DRUG STREAMING DURING INTRAARTERIAL CHEMOTHERAPY [J].
BLACKLOCK, JB ;
WRIGHT, DC ;
DEDRICK, RL ;
BLASBERG, RG ;
LUTZ, RJ ;
DOPPMAN, JL ;
OLDFIELD, EH .
JOURNAL OF NEUROSURGERY, 1986, 64 (02) :284-291
[2]
BOBO H, 1992, J NEURO-ONCOL, V13, P291
[3]
CHIRAS J, 1992, INTERV NEURORADIOL, P181
[4]
Intra-arterial Cereport (RMP-7) and carboplatin: A dose escalation study for recurrent malignant gliomas [J].
Cloughesy, TF ;
Black, KL ;
Gobin, YP ;
Farahani, K ;
Nelson, G ;
Villablanca, P ;
Kabbinavar, F ;
Vineula, F ;
Wortel, CH .
NEUROSURGERY, 1999, 44 (02) :270-278
[5]
Intra-arterial carboplatin chemotherapy for brain tumors: A dose escalation study based on cerebral blood flow [J].
Cloughesy, TF ;
Gobin, YP ;
Black, KL ;
Vinuela, F ;
Taft, F ;
Kadkhoda, B ;
Kabbinavar, F .
JOURNAL OF NEURO-ONCOLOGY, 1997, 35 (02) :121-131
[6]
PHARMACOLOGIC RATIONALE FOR REGIONAL DRUG DELIVERY [J].
COLLINS, JM .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) :498-504
[7]
Dahlborg SA, 1998, CANCER J, V4, P110
[9]
Phase II study of intracarotid or selective intracerebral infusion of cisplatin for treatment of recurrent anaplastic gliomas [J].
Dropcho, EJ ;
Rosenfeld, SS ;
Vitek, J ;
Guthrie, BL ;
Morawetz, RB .
JOURNAL OF NEURO-ONCOLOGY, 1998, 36 (02) :191-198
[10]
TREATMENT OF MALIGNANT GLIOMAS WITH SURGERY, INTRAARTERIAL INFUSIONS OF 1-(2-HYDROXYETHYL)CHLOROETHYLNITROSOUREA, AND RADIATION-THERAPY - A PHASE-II STUDY [J].
FAUCHON, F ;
DAVILA, L ;
CHATELLIER, G ;
FOHANNO, D ;
PHILIPPON, J ;
REY, A ;
CHIRAS, J ;
POISSON, M ;
DELATTRE, JY .
NEUROSURGERY, 1990, 27 (02) :231-234